Their data showed increased accumulation of these nanoparticles inside TME in vivo, PD-L1 inhibition via microRNAs and the induction of a more immunogenic tumor microenvironment, also exhibiting increased dendritic cells maturation and CD8+ T cell response towards cancer cells (162). The gene discussed is CD8A; the disease is neoplasm.